NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET

4/17/26 3:37:00 PM ET

Medical/Dental Instruments

Health Care

Get the next $NXGL alert in real time by email

LANGHORNE, Pa., April 17, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it is moving up its shareholder update conference call from Thursday, April 23^rd to Tuesday, April 21^st, 2026, at 4:30 P.M. ET.

Shareholder Update Call Details:

Date: April 21, 2026

Time: 4:30 P.M. ET

Live Call: 1-800-267-6316 (U.S. Toll Free) or 1-203-518-9783 (International)

Webcast: Events and Presentations

About NEXGEL, Inc.

NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include SilverSeal^®, Hexagels^®, Turfguard^®, Kenkoderm^® and Silly George^®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

Investor Contact:

Valter Pinto, Managing Director

KCSA Strategic Communications

212.896.1254

Nexgel@KCSA.com

Get the next $NXGL alert in real time by email

Date

Price Target

Rating

Analyst

2/25/2022

$6.00

Buy

Maxim Group

NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$NXGL

NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$NXGL

$NXGL
Insider Purchases

Chief Executive Officer Levy Adam R. bought $9,999 worth of shares (3,636 units at $2.75), increasing direct ownership by 1% to 333,196 units (SEC Form 4)

Director Zeldis Jerome B bought $9,999 worth of shares (3,636 units at $2.75), increasing direct ownership by 4% to 106,664 units (SEC Form 4)

Director Stein John Nachum gifted 4,000 shares and bought $9,999 worth of shares (3,636 units at $2.75), decreasing direct ownership by 0.08% to 471,456 units (SEC Form 4)

$NXGL
SEC Filings

SEC Form PRE 14A filed by NexGel Inc

SEC Form 10-Q filed by NexGel Inc

NexGel Inc filed SEC Form 8-K: Financial Statements and Exhibits

$NXGL
Press Releases

NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th

NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration

NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical

$NXGL
Analyst Ratings

Maxim Group initiated coverage on NexGel with a new price target

$NXGL
Insider Trading

Chief Executive Officer Levy Adam R. sold $1,172 worth of shares (2,000 units at $0.59), decreasing direct ownership by 0.58% to 342,692 units (SEC Form 4)

Chief Executive Officer Levy Adam R. sold $7,834 worth of shares (13,000 units at $0.60), decreasing direct ownership by 4% to 344,692 units (SEC Form 4)

SEC Form 4 filed by Director Henry Scott Robert

$NXGL
Leadership Updates

NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical

NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors

NEXGEL Appoints Ian Blackman as Chief Financial Officer

$NXGL
Financials

NEXGEL To Report First Quarter 2026 Financial Results on May 15th